After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook Is Bright

Yahoo FinanceNov 19 22:55

Piper Sandler Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 13 21:36 · Ratings

Milestone Pharmaceuticals (MIST) Gets a Buy From Piper Sandler

TipRanksNov 13 21:22 · Ratings

Strategic Positioning and Financial Outlook: Ritu Baral's Buy Rating on Milestone Pharmaceuticals Amidst Etripamil's Promising Market Launch

TipRanksNov 13 13:15 · Ratings

Express News | Milestone Pharmaceuticals Files for Mixed Shelf Offering of up to $250 Mln - SEC Filing

BreakingsNov 13 05:40

Milestone Pharmaceuticals Prepares for CARDAMYST Approval

TipRanksNov 13 00:38